ARLENE PARKER: Open Payments
NPI 1912698549 · MARTINSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 32 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $483 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 13 | $184 |
| Janssen Pharmaceuticals, Inc | 5 | $107 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| ABBVIE INC. | 1 | $29 |
| Neos Therapeutics, LP | 1 | $23 |
| Corium, LLC | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
Products named: FANAPT, SPRAVATO, Auvelity, CAPLYTA, REXULTI, VRAYLAR, EXXUA, Azstarys.
Industry payments across IN — which companies pay providers there.
